UK researchers track Real-World results of leukemia drug

NCT ID NCT05557695

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is collecting information on how well the drug acalabrutinib works for patients with chronic lymphocytic leukemia (CLL) in real-world UK clinics. It will look back at the medical records of about 350 adults who started this treatment through a special early access program. The goal is to understand how long patients live without their cancer getting worse, their overall survival, and how the treatment is used in everyday practice.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Aylesbury, United Kingdom
Research Site
RECRUITING

Bath, United Kingdom
Research Site
RECRUITING

Birmingham, United Kingdom
Research Site
RECRUITING

Bournemouth, United Kingdom
Research Site
RECRUITING

Cardiff, United Kingdom
Research Site
RECRUITING

Cornwall, United Kingdom
Research Site
RECRUITING

Dartford, United Kingdom
Research Site
RECRUITING

Derby, United Kingdom
Research Site
RECRUITING

Doncaster, United Kingdom
Research Site
RECRUITING

Dorset, United Kingdom
Research Site
RECRUITING

Eastbourne, United Kingdom
Research Site
RECRUITING

Hull, United Kingdom
Research Site
RECRUITING

Leicester, United Kingdom
Research Site
RECRUITING

Lincoln, United Kingdom
Research Site
RECRUITING

Liverpool, United Kingdom
Research Site
RECRUITING

London, SE1 9RT, United Kingdom
Research Site
RECRUITING

London, W12 OHS, United Kingdom
Research Site
RECRUITING

Mid Yorkshire, United Kingdom
Research Site
RECRUITING

Middlesbrough, United Kingdom
Research Site
RECRUITING

Newcastle, United Kingdom
Research Site
RECRUITING

North Shields, United Kingdom
Research Site
RECRUITING

Norwich, United Kingdom
Research Site
RECRUITING

Nottingham, United Kingdom
Research Site
RECRUITING

Oxford, United Kingdom
Research Site
RECRUITING

Plymouth, United Kingdom
Research Site
RECRUITING

Southampton, United Kingdom
Research Site
RECRUITING

Stockton-on-Tees, United Kingdom
Research Site
RECRUITING

Stoke-on-Trent, United Kingdom
Research Site
RECRUITING

Wigan, United Kingdom

Conditions

Explore the condition pages connected to this study.

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)